Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Assessment of Abuse Potential of Drugs

Assessment of Abuse Potential of Drugs

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

January 18, 2017

February 3, 2025

Center for Drug Evaluation and Research

6c9a2ccd-021a-4f93-a97e-5444b6de4fef

Related Documents

Botanical Drug Development: Guidance for Industry

Guidance DocumentDecember 29, 2016Center for Drug Evaluation and Research
View Details →

Good ANDA Submission Practices Guidance for Industry

Guidance DocumentJanuary 26, 2022Center for Drug Evaluation and Research
View Details →

Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals

Guidance DocumentJune 5, 2023Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.